by Jordana Choucair | Jul 14, 2022 | Payers
Senator Joe Manchin said that he’s wary of adding an extension for enhanced subsidies for ACA plans to a slimmer reconciliation package, citing a fear of anything he believes would contribute “to the horrible inflation triggers we have.” Insurers and...
by Jordana Choucair | Jul 13, 2022 | Access & Coverage
The White House Council of Economic Advisers (CEA) authored a new issue brief revealing that states with high uninsured rates saw more “excess deaths” during the COVID-19 pandemic that stemmed from reasons like meager care in overwhelmed hospitals. The CEA...
by Jordana Choucair | Jul 13, 2022 | Life Sciences
The Food and Drug Administration (FDA) is expected to authorize Novavax’s coronavirus vaccine for emergency use as early as today. The authorization would likely permit the two-dose vaccine to be given to adults as a primary immunization series, limiting its use in...
by Jordana Choucair | Jul 13, 2022 | Life Sciences
Merck filed a lawsuit against the Biden administration to avoid potential fines for cutting off 340B contract pharmacies from getting discounted products. In 2021, Merck, along with nearly 20 drugmakers, cut off sales of 340B-discounted drugs to contract pharmacies,...
by Jordana Choucair | Jul 13, 2022 | Opioid/Substance Use Disorders
Teva Pharmaceutical Industries Ltd. and AbbVie Inc.’s Allergan unit will pay $34 million in cash and $20 million worth of overdose reversal drug Narcan to settle a federal lawsuit brought by San Francisco alleging that the drugmakers fueled the opioid surge,...
by Jordana Choucair | Jul 13, 2022 | Providers
A Centers for Disease Control and Prevention (CDC) analysis found that superbug infections and deaths in U.S. hospitals jumped approximately 15 percent in 2020. From 2012 to 2017, a public health push to stamp out superbug infections in hospitals resulted in a 30...
Recent Comments